HERE’S HOW IT WORKS.
The MiniMed™ 770G system combines insulin pump therapy and continuous glucose monitoring (CGM). It’s able to make adjustments to the amount of background insulin delivered based on your child’s needs, helping reduce highs and lows.*
The system also makes delivering insulin at mealtimes easy. Simply enter the number of carbs that will be consumed, and the system can automatically calculate a mealtime insulin dose.
The MiniMed™ 770G system uses Bluetooth® technology to display data on your smartphone. To learn more about this feature, take a look at this video!
MINIMED™ 770G SYSTEM
Calculates background insulin needed based on sensor glucose and delivers it to the body through a small tube.*
Measures sugar levels every five minutes and sends readings wirelessly to the pump.
Allows you to view sugar levels and trends on a phone. Plus you can see insulin delivery history too!
HERE'S WHAT YOU GET
The MiniMed™ 770G system self-adjusts background insulin every five minutes using technology called SmartGuard™ Auto Mode.
This feature can help reduce highs and lows. With fewer highs and lows, the system may help your child achieve better glucose control.
SMARTPHONE APPFOR YOUR CHILD
The MiniMed™ Mobile app allows your child to view pump and CGM information on a phone.
The app displays sugar levels and insulin delivery history. Plus, your child can receive an alert if sugar levels are trending high or low.
SMARTPHONE APPFOR CARE PARTNERS
See your child's information on your phone with the CareLink™ Connect app.
The app displays sugar levels and trends, plus insulin delivery history so you can stay in the know. You can be alerted** when your child’s sugars go high or low.
MINIMED™ 770G SYSTEM
GET STARTED HERE!
We’re excited you’re ready to learn more about insulin pump therapy options for your child.
Fill out the form below and we’ll follow up with you. Please note, we’re preparing to take orders for this new system, so it could be a few weeks until you hear from us!
* Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.
** To receive app notifications, an internet connection is required.
† Program eligibility requirements and terms and conditions apply. Subject to change.
Actor portrayal used on this webpage
Bluetooth is a registered trademark
Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide Test Strips. The system requires a prescription.The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than eight units or more than 250 units of total daily insulin per day. A total daily dose of at least eight units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library